Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 11期
关键词：
D O I：
10.1055/a-2111-0905
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Menschen mit einem fortgeschrittenen nichtkleinzelligen Lungenkarzinom (NSCLC) haben eine schlechte uberlebensprognose. Liegt eine KRAS G12C-Mutation vor, profitieren sie den Ergebnissen der CodeBreak 100-Studie zu Folge von Sotorasib, einem spezifischen und irreversiblen KRAS-Inhibitor. Nun berichten die Studieninitiatorinnen und -initiatoren die 2-Jahres-Datenauswertung bezuglich der Effektivitat, der Sicherheit sowie molekularer Biomarker.
引用
收藏
页码：846 / 846
页数：1
相关论文
共 50 条
  • [21] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [22] Safety and efficacy of HS-10370 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Dong, Xiaorong
    Meng, Xiangjiao
    Zhang, Yan
    Wang, Yan
    Chen, Jianhua
    Han, Liang
    Wang, Qiming
    Lin, Zhong
    Wei, Hongying
    Lin, Siheng
    Li, Chuan
    Wu, Qiong
    CANCER RESEARCH, 2024, 84 (07)
  • [23] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
  • [24] Differences on immune biomarkers between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer
    Pinto, L. Masfarre
    Parreira, A. S. D. F. M.
    Unanua, N. Castro
    Rocha, P.
    Ruiz, I. Morilla
    Sanchez, L. Teijeira
    Clave, S.
    Gorro, N. Navarro
    Mora, R. Bach
    Sanchez, I.
    Campos, M. A. Galindo
    Garcia, A. Taus
    Martinez, A. Azkarate
    Fabregat, R. Marse
    Paricio, B. Bellosillo
    Arasanz, H.
    Aguillo, M. Martinez
    Arriola, E.
    ANNALS OF ONCOLOGY, 2023, 34
  • [25] Sotorasib Shows Intracranial Activity in Patients with KRAS G12C-Mutated Adenocarcinoma of the Lung and Untreated Active Brain Metastases
    Koster, Kira-Lee
    Appenzeller, Christina
    Lauber, Arno
    Fruh, Martin
    Schmid, Sabine
    CASE REPORTS IN ONCOLOGY, 2022, 15 (02): : 720 - 725
  • [26] Sotorasib in KRAS G12C-mutated advanced non-small cell lung cancer (aNSCLC): Overall survival (OS) data from the global expanded access program (EAP study-436)
    Novello, S.
    Maimon, N.
    Stevenson, J. P.
    Petty, W.
    Ferreira, C. G. M.
    Morbeck, I.
    Zer, A.
    Bauman, J. R.
    Kalmadi, S.
    Xia, C.
    Meloni, A.
    Varrieur, T.
    Awad, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S40 - S41
  • [27] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [28] Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas
    Pirlog, Radu
    Piton, Nicolas
    Lamy, Aude
    Guisier, Florian
    Berindan-Neagoe, Ioana
    Sabourin, Jean-Christophe
    Marguet, Florent
    CANCERS, 2022, 14 (04)
  • [29] Efficacy of JS']JSI-1187 or VIC-1911 in combination with KRAS G12C inhibitors for the treatment of KRAS G12C-mutated non-small cell lung cancer and colorectal cancer
    Zhang, Lei
    Li, Ao
    Jian, Shanzhong
    Du, Chengyi
    Zhu, Wan
    Tao, Yue
    Wang, Meiwei
    Xu, Wen
    Hao, Wenshan
    Paradiso, Linda
    Myers, Thomas
    Koya, Keizo
    Zhang, Jintao
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Biomarker subgroup analyses of CodeBreaK 200, a phase 3 trial of sotorasib versus (vs) docetaxel in patients (pts) with pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC)
    Skoulidis, Ferdinandos
    De langen, Adrianus
    Paz-Ares, Luis G.
    Mountzios, Giannis Socrates
    Curioni-Fontecedro, Alessandra
    Couraud, Sebastien
    Janssens, Annelies
    Rocco, Danilo
    Ohashi, Kadoaki
    Vincent, Mark David
    Kang, Jin-Hyoung
    Schvartsman, Gustavo
    Lindsay, Colin R.
    O'Byrne, Kenneth John
    Dziadziuszko, Rafal
    Andersen, Jon A. Lykkegaard
    Hindoyan, Antreas
    Wilmanski, Tomasz
    Wang, Yang
    Schuler, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345